Use QuickSwitch™ Class II Quant Tetramer to investigate peptide-MHC binding affinities & conclude with your specialised CD4+ T cell detection reagent!
The Importance of In Vivo Isotype Controls in Advancing Therapeutic Drug Development
MBLI offer a webinar that addresses the FAQs they receive from researchers. They have also included information to assist in designing in vivo studies.
Introducing MBLI’s easy-to-use Western Reagents
MBL Western Substrates are highly sensitive & compatible chemiluminescent substrates for use with immunoblots with HRP-conjugated secondary antibodies
Protective Role of Invariant Natural Killer T (iNKT) cells
CD1d, non-classical MHC molecules, present phospholipid & glycosphingolipid antigens to iNKT cells. MBL tetramers help measure CD1d positive NKT cells
2023 Advancements in Research with QuickSwitch™ Custom Tetramer Kits
Here are the highlights of some of the influential publications that have utilised MBLI QuickSwitch™ Tetramer Kits in 2023.
Respiratory Syncytial Virus (RSV): Continued Research for the Most Prevalent Respiratory Virus Among Children
RSV is a significant respiratory virus in young children, & is the primary cause of hospitalisations, particularly bronchiolitis & pneumonia.
Advancements in the understanding of m7G Modification
There is more data that highlights the significant role of m7G modification in human diseases, particularly cancer.
New Innovative Product: Human R-spondin 1: Organoid Culture
MBL have a new innovative product available: Human R-spondin 1, for use in organoid culture.
The Impact of In Vivo Isotype Controls on Therapeutic Drug Development
In vivo antibody studies offer a wide range of applications. Discover the significant impact of antibody selection on your experiment.
Key Growth Factors in Organoid Culture
MBL’s FGF-Max a recombinant chimeric protein, which includes both FGF-1 and FGF-2 solves the issues of using commercially available FGF-1.